AmbrosiniPJ: A pharmacological paradigm for urinary incontinence and enuresis. J Clin Psychopharmacol, 4:247–253, 1984.
2.
DebS, FarmahBK, ArshadE, DebT, RoyM, UnwinGL: The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder—a systematic review. Res Dev Disabil, 35:711–725, 2014.
3.
HergünerS, KilinçaslanA, GörkerI, TüzünU: Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases. J Child Adolesc Psychopharmacol, 17:367–369, 2007.
4.
HergünerS, MukaddesNM: Risperidone-induced enuresis in two children with autistic disorder. J Child Adolesc Psychopharmacol, 17:527–530, 2007.
5.
KarakurtMN, SürenS: Desmopressin use in the treatment of aripiprazole-induced nocturnal enuresis in a child diagnosed with autıstıc disorder. J Child Adolesc Psychopharmacol, 25:518–519, 2015.
6.
LeeMJ, KimCE: Use of aripiprazole in clozapine induced enuresis: Report of two cases. J Korean Med Sci, 25:333–335, 2010.
7.
LeiS: Cross interaction of dopaminergic and adrenergic systems in neural modulation. Int J Physiol Pathophysiol Pharmacol, 6:137–142, 2014.
8.
OwenR, SikichL, MarcusRN, Corey-LisleP, ManosG, McQuadeRD, CarsonWH, FindlingRL: Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124:1533–1540, 2009.
9.
RamageAG: The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition. Br J Pharmacol, 147Suppl 2:S120–S131, 2006.
10.
WilliamsonLB, GowerM, UlzenT: Clinical case rounds in child and adolescent psychiatry: Enuresis and ADHD in older children and an adolescent treated with stimulant medication: A case series. J Can Acad Child Adolesc Psychiatry, 20:53–55, 2011.
